← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Northrop Grumman: Revenue grew 2.2% to $41.954B from $41.033B. Net income grew 0.2% to $4.182B from $4.174B. Free cash flow grew 26.2% to $3.307B from $2.621B. Operating margin expanded 10 bps to 10.75%. Northrop Grumman's annual comparison also shows stock compensation grew faster than revenue.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 2.2%OK
- Profitability — Net income grew 0.2% to $4.182B from $4.174BOK
- Cash flow — Free cash flow grew 26.2% to $3.307B from $2.621BOK
- Margins — Operating margin expanded 10 bps to 10.75%OK
- Accounting — No overriding statistical warningNote
- Insiders — 0 purchases and 17 salesWatch
Business
Northrop Grumman develops aerospace, defense, mission and space systems.
Where the revenue comes from
Fiscal 2025, as NORTHROP GRUMMAN CORP /DE/ reports it. History and quarterly detail are in the app.
- Product$33.7B
- Service$8.2B
Leadership changes
From NORTHROP GRUMMAN CORP /DE/'s own filings, the day they're filed.
- Madeleine A. Kleiner · Director · departureeff. 2026-05-20
- Kenneth Crews · chief financial officer · departureeff. 2026-01-07
- Northrop Grumman · President · appointmenteff. 2024-10-01
Latest filings
- 8-K · Company announcement2026-08-21
- 10-Q · Quarterly report2026-07-21
- 8-K · Company announcement2026-07-21
- 8-K · Company announcement2026-05-21
- 10-Q · Quarterly report2026-04-21
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about NORTHROP GRUMMAN CORP /DE/, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.